These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacy. Gogliotti RD; Engers DW; Garcia-Barrantes PM; Panarese JD; Gentry PR; Blobaum AL; Morrison RD; Daniels JS; Thompson AD; Jones CK; Conn PJ; Niswender CM; Lindsley CW; Hopkins CR Bioorg Med Chem Lett; 2016 Jun; 26(12):2915-2919. PubMed ID: 27131990 [TBL] [Abstract][Full Text] [Related]
4. Discovery and optimization of a novel CNS penetrant series of mGlu Kent CN; Fulton MG; Stillwell KJ; Dickerson JW; Loch MT; Rodriguez AL; Blobaum AL; Boutaud O; Rook JL; Niswender CM; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2021 Apr; 37():127838. PubMed ID: 33556572 [TBL] [Abstract][Full Text] [Related]
5. Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 3. Engineering plasma stability by discovery and optimization of isoindolinone analogs. Garcia-Barrantes PM; Cho HP; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2016 Apr; 26(8):1869-72. PubMed ID: 26988302 [TBL] [Abstract][Full Text] [Related]
6. Lead optimization of the VU0486321 series of mGlu(1) PAMs. Part 2: SAR of alternative 3-methyl heterocycles and progress towards an in vivo tool. Garcia-Barrantes PM; Cho HP; Metts AM; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2016 Feb; 26(3):751-756. PubMed ID: 26778256 [TBL] [Abstract][Full Text] [Related]
7. The discovery of VU0486846: steep SAR from a series of M Bertron JL; Cho HP; Garcia-Barrantes PM; Panarese JD; Salovich JM; Nance KD; Engers DW; Rook JM; Blobaum AL; Niswender CM; Stauffer SR; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2018 Jul; 28(12):2175-2179. PubMed ID: 29754948 [TBL] [Abstract][Full Text] [Related]
8. Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5). Martín-Martín ML; Bartolomé-Nebreda JM; Conde-Ceide S; Alonso de Diego SA; López S; Martínez-Viturro CM; Tong HM; Lavreysen H; Macdonald GJ; Steckler T; Mackie C; Bridges TM; Daniels JS; Niswender CM; Noetzel MJ; Jones CK; Conn PJ; Lindsley CW; Stauffer SR Bioorg Med Chem Lett; 2015 Mar; 25(6):1310-7. PubMed ID: 25683622 [TBL] [Abstract][Full Text] [Related]
9. Re-exploration of the mGlu₁ PAM Ro 07-11401 scaffold: Discovery of analogs with improved CNS penetration despite steep SAR. Garcia-Barrantes PM; Cho HP; Starr TM; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2016 May; 26(9):2289-92. PubMed ID: 27013388 [TBL] [Abstract][Full Text] [Related]
10. Discovery of dihydropyrazino-benzimidazole derivatives as metabotropic glutamate receptor-2 (mGluR2) positive allosteric modulators (PAMs). Szabó G; Kolok S; Orgován Z; Vastag M; Béni Z; Kóti J; Sághy K; Lévay GI; Greiner I; Keserű GM Eur J Med Chem; 2020 Jan; 186():111881. PubMed ID: 31780081 [TBL] [Abstract][Full Text] [Related]
11. Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers. Niswender CM; Jones CK; Lin X; Bubser M; Thompson Gray A; Blobaum AL; Engers DW; Rodriguez AL; Loch MT; Daniels JS; Lindsley CW; Hopkins CR; Javitch JA; Conn PJ ACS Chem Neurosci; 2016 Sep; 7(9):1201-11. PubMed ID: 27441572 [TBL] [Abstract][Full Text] [Related]
12. Discovery and SAR of a novel series of non-MPEP site mGlu₅ PAMs based on an aryl glycine sulfonamide scaffold. Rodriguez AL; Zhou Y; Williams R; Weaver CD; Vinson PN; Dawson ES; Steckler T; Lavreysen H; Mackie C; Bartolomé JM; Macdonald GJ; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Stauffer SR Bioorg Med Chem Lett; 2012 Dec; 22(24):7388-92. PubMed ID: 23142615 [TBL] [Abstract][Full Text] [Related]
13. Lead optimization of the VU0486321 series of mGlu Davis DC; Bungard JD; Chang S; Rodriguez AL; Blobaum AL; Boutaud O; Melancon BJ; Niswender CM; Jeffrey Conn P; Lindsley CW Bioorg Med Chem Lett; 2021 Jan; 32():127724. PubMed ID: 33253881 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and SAR of a series of mGlu Kalbfleisch JJ; Reed CW; Park C; Spearing PK; Quitalig MC; Jenkins MT; Rodriguez AL; Blobaum AL; Conn PJ; Niswender CM; Lindsley CW Bioorg Med Chem Lett; 2020 Nov; 30(22):127529. PubMed ID: 32890686 [TBL] [Abstract][Full Text] [Related]
15. Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headache. Blanco MJ; Benesh DR; Knobelsdorf JA; Khilevich A; Cortez GS; Mokube F; Aicher TD; Groendyke TM; Marmsater FP; Tang TP; Johnson KW; Clemens-Smith A; Muhlhauser MA; Swanson S; Catlow J; Emkey R; Johnson MP; Schkeryantz JM Bioorg Med Chem Lett; 2017 Jan; 27(2):323-328. PubMed ID: 27908761 [TBL] [Abstract][Full Text] [Related]